Codexis (CDXS) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Codexis Revenue Highlights

Latest Revenue (Y)

$70.39M

Latest Revenue (Q)

$15.25M

Main Segment (Y)

Research And Development Revenue

Main Geography (Y)

Americas

Codexis Revenue by Period

Codexis Revenue by Year

Date	Revenue	Change
2025-12-31	$70.39M	18.61%
2024-12-31	$59.34M	-15.39%
2023-12-31	$70.14M	-49.39%
2022-12-31	$138.59M	32.30%
2021-12-31	$104.75M	51.69%
2020-12-31	$69.06M	0.87%
2019-12-31	$68.46M	12.98%
2018-12-31	$60.59M	21.13%
2017-12-31	$50.02M	2.43%
2016-12-31	$48.84M	16.82%
2015-12-31	$41.80M	18.40%
2014-12-31	$35.31M	10.60%
2013-12-31	$31.92M	-63.85%
2012-12-31	$88.30M	-28.71%
2011-12-31	$123.86M	15.65%
2010-12-31	$107.10M	29.18%
2009-12-31	$82.91M	64.25%
2008-12-31	$50.48M	99.26%
2007-12-31	$25.33M	108.90%
2006-12-31	$12.13M	-

Codexis generated $70.39M in revenue during NA 2025, up 18.61% compared to the previous quarter, and up 101.93% compared to the same period a year ago.

Codexis Revenue by Quarter

Date	Revenue	Change
2026-03-31	$15.25M	-60.82%
2025-12-31	$38.91M	352.45%
2025-09-30	$8.60M	-43.89%
2025-06-30	$15.33M	103.21%
2025-03-31	$7.54M	-64.85%
2024-12-31	$21.46M	67.23%
2024-09-30	$12.83M	60.83%
2024-06-30	$7.98M	-53.27%
2024-03-31	$17.07M	-35.72%
2023-12-31	$26.56M	186.31%
2023-09-30	$9.28M	-56.49%
2023-06-30	$21.32M	64.25%
2023-03-31	$12.98M	-57.26%
2022-12-31	$30.38M	-11.88%
2022-09-30	$34.47M	-10.25%
2022-06-30	$38.41M	8.68%
2022-03-31	$35.34M	44.24%
2021-12-31	$24.50M	-33.37%
2021-09-30	$36.77M	44.46%
2021-06-30	$25.45M	41.15%
2021-03-31	$18.03M	-14.27%
2020-12-31	$21.03M	14.40%
2020-09-30	$18.39M	22.84%
2020-06-30	$14.97M	2.02%
2020-03-31	$14.67M	-21.34%
2019-12-31	$18.65M	-14.86%
2019-09-30	$21.91M	77.82%
2019-06-30	$12.32M	-20.95%
2019-03-31	$15.58M	-3.02%
2018-12-31	$16.07M	-5.18%
2018-09-30	$16.95M	25.17%
2018-06-30	$13.54M	-3.59%
2018-03-31	$14.04M	-35.36%
2017-12-31	$21.72M	117.57%
2017-09-30	$9.98M	-3.51%
2017-06-30	$10.35M	29.81%
2017-03-31	$7.97M	-20.04%
2016-12-31	$9.97M	-32.96%
2016-09-30	$14.87M	-7.07%
2016-06-30	$16.00M	100.13%
2016-03-31	$8.00M	-30.99%
2015-12-31	$11.59M	-33.42%
2015-09-30	$17.40M	189.15%
2015-06-30	$6.02M	-11.47%
2015-03-31	$6.80M	-52.10%
2014-12-31	$14.19M	89.92%
2014-09-30	$7.47M	13.73%
2014-06-30	$6.57M	-7.12%
2014-03-31	$7.07M	-25.73%
2013-12-31	$9.53M	141.57%
2013-09-30	$3.94M	-43.46%
2013-06-30	$6.97M	-39.26%
2013-03-31	$11.48M	45.11%
2012-12-31	$7.91M	-69.96%
2012-09-30	$26.34M	14.98%
2012-06-30	$22.91M	-26.42%
2012-03-31	$31.14M	-7.04%
2011-12-31	$33.49M	0.63%
2011-09-30	$33.28M	27.74%
2011-06-30	$26.05M	-16.04%
2011-03-31	$31.03M	4.10%
2010-12-31	$29.81M	9.95%
2010-09-30	$27.11M	10.76%
2010-06-30	$24.48M	-4.75%
2010-03-31	$25.70M	6.03%
2009-12-31	$24.24M	20.82%
2009-09-30	$20.06M	4.50%
2009-06-30	$19.20M	-1.09%
2009-03-31	$19.41M	4.37%
2008-12-31	$18.60M	122.09%
2008-03-31	$8.37M	78.02%
2007-03-31	$4.70M	-

Codexis generated $15.25M in revenue during Q1 2026, up -60.82% compared to the previous quarter, and up 71.05% compared to the same period a year ago.

Codexis Revenue Breakdown

Codexis Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 22	Dec 21	Dec 20
Product	$26.03M	$36.79M	-	-	-
Research And Development Revenue	$44.36M	-	-	-	-
Research and Development Revenue	-	$22.56M	$1.61M	$3.05M	$2.30M
Sitagliptin Enzyme	-	$2.50M	$1.60M	$2.80M	-
Enzyme Product	-	-	$75.40M	$1.70M	-
Product Sales	-	-	$29.00M	$3.28M	$2.49M
Service	-	-	-	$34.10M	$38.84M

Codexis's latest annual revenue breakdown by segment (product or service), as of Dec 25: Research And Development Revenue (63.02%), and Product (36.98%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
Product	$7.19M	$5.78M	$6.81M	$7.38M	$6.06M	$25.63M	$11.16M	$18.68M	$19.10M	$8.37M	-	-	-	-	-	-	-	-	-	-
Research and Development Revenue	$8.06M	$1.79M	$7.95M	$20.88M	$1.68M	$3.88M	$1.54M	$7.50M	$7.08M	$1.47M	$2.33M	$2.10M	$7.52M	$3.36M	$3.50M	$1.98M	$8.82M	-	-	-
Research And Development Revenue	-	$42.88M	$1.48M	$7.52M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product Sales	-	-	-	-	-	-	-	$10.49M	$21.38M	$3.05M	$2.97M	$16.98M	$2.84M	$1.98M	$2.82M	$12.21M	-	-	-	-
Enzyme Product	-	-	-	-	-	-	-	-	-	-	-	$19.80M	-	-	-	-	-	-	-	-

Codexis's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Research and Development Revenue (52.84%), and Product (47.16%).

Codexis Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 22	Dec 21	Dec 20
IRELAND	$700.00K	$1.80M	-	-	-
SINGAPORE	$400.00K	$6.20M	-	-	-
UNITED STATES	$43.50M	$21.30M	-	-	-
SWITZERLAND	$4.20M	$3.40M	-	-	-
Americas	$43.54M	$21.28M	$17.00M	$23.48M	$24.35M
Asia Pacific	$17.56M	$27.71M	$65.05M	$61.09M	-
CHINA	$9.30M	$9.80M	-	-	-
EMEA	$9.29M	$10.36M	$56.54M	$20.19M	$19.26M
INDIA	$5.70M	$7.30M	-	-	-
APAC	-	-	-	-	$25.45M

Codexis's latest annual revenue breakdown by geography, as of Dec 25: Americas (32.45%), UNITED STATES (32.42%), Asia Pacific (13.08%), CHINA (6.93%), EMEA (6.92%), INDIA (4.25%), SWITZERLAND (3.13%), IRELAND (0.52%), and SINGAPORE (0.30%).

Quarterly Revenue by Country

Country	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Sep 23	Dec 21	Sep 21	Dec 19	Jun 18	Mar 18
APAC	$5.33M	$6.06M	$6.58M	$1.54M	$9.07M	$7.26M	$1.81M	$2.77M	-	-	-	-	-	-
Americas	$7.86M	$33.53M	$1.57M	$6.35M	$2.09M	$12.50M	$1.53M	$7.24M	$4.28M	$3.42M	-	-	-	-
EMEA	$2.06M	$2.00M	$972.00K	$2.40M	$3.92M	$5.56M	$2.23M	$2.57M	$3.19M	$12.46M	$1.44M	$1.68M	-	-
Asia Pacific	-	-	-	-	-	-	-	-	-	$16.56M	$24.27M	-	-	-

Codexis's latest quarterly revenue breakdown by geography, as of Mar 26: Americas (51.55%), APAC (34.95%), and EMEA (13.50%).

Codexis Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CDXS	Codexis	$70.39M	$15.25M
SGMO	Sangamo Therapeutics	$57.80M	$581.00K
IVVD	Invivyd	$53.43M	$13.13M
IPHA	Innate Pharma	$51.90M	$16.56M
GNFT	Genfit	$28.57M	$17.08M
OABI	OmniAb	$18.67M	$14.43M
IMDX	Insight Molecular Diagnostics	$4.05M	$32.00K
CCCC	C4 Therapeutics	-	-
TARA	Protara Therapeutics	-	-
RANI	Rani Therapeutics	-	-

CDXS Revenue FAQ

What is Codexis’s yearly revenue?

Codexis's yearly revenue for 2025 was $70.39M, representing an increase of 18.61% compared to 2024. The company's yearly revenue for 2024 was $59.34M, representing a decrease of -15.39% compared to 2023. CDXS's yearly revenue for 2023 was $70.14M, representing a decrease of -49.39% compared to 2022.

What is Codexis’s quarterly revenue?

Codexis's quarterly revenue for Q1 2026 was $15.25M, a -60.82% decrease from the previous quarter (Q4 2025), and a 102.15% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $38.92M, a 352.45% increase from the previous quarter (Q3 2025), and a 81.34% increase year-over-year (Q4 2024). CDXS's quarterly revenue for Q3 2025 was $8.6M, a -43.89% decrease from the previous quarter (Q2 2025), and a -32.98% decrease year-over-year (Q3 2024).

What is Codexis’s revenue growth rate?

Codexis's revenue growth rate for the last 3 years (2023-2025) was 0.35%, and for the last 5 years (2021-2025) was -32.81%.

What are Codexis’s revenue streams?

Codexis's revenue streams in c 25 are Product, and Research And Development Revenue. Product generated $26.03M in revenue, accounting 36.98% of the company's total revenue, down -29.24% year-over-year. Research And Development Revenue generated $44.36M in revenue, accounting 63.02% of the company's total revenue

What is Codexis’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Codexis was Research And Development Revenue. This segment made a revenue of $44.36M, representing 63.02% of the company's total revenue.